In addition, mutations of NOTCH1 have been discovered in nearly 60% of T-ALL patients, which underpins the importance of aberrant activation of NOTCH1 in leukemogenesis (12). This evidence concerns the gene NOTCH1 and acute lymphoblastic leukemia.